
Julian Panés
Jefe de la UnidadFeatured publications
-
Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's disease
Authors: Ordás I, Rimola J, Alfaro I, Rodríguez S, Castro-Poceiro J, Ramírez-Morros A, Gallego M, Giner À, Barastegui R, Fernández-Clotet A, Masamunt M, Ricart E, Panés J .Reference: Gastroenterology 2019. -
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Authors: Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Diez MC, Tagarro I, Leselbaum A, Danese S, ADMIRE CD Study Group Collaborators.Reference: Gastroenterology 2018. -
Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis
Authors: Dotti I., Mora-Buch R., Ferrer-Picón E., Planell N., Jung P., Masamunt M., Leal R., De Carpi J., Llach J., Ordás I., Batlle E., Panés J., Salas A..Reference: Gut 2017. -
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.
Authors: Panés J, Sandborn WJ, Schreiber S, Sands BE, Vermeire S, D'Haens G, Panaccione R, Higgins PDR, Colombel JF, Feagan BG, Chan G, Moscariello M, Wang W, Niezychowski W, Marren A, Healey P, Maller E .Reference: Gut 2017. -
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Authors: Sandborn, William J.; Su, Chinyu; Sands, Bruce E.; D'Haens, Geert R.; Vermeire, Severine; Schreiber, Stefan; Danese, Silvio; Feagan, Brian G.; Reinisch, Walter; Niezychowski, Wojciech; Friedman, Gary; Lawendy, Nervin; Yu, Dahong; Woodworth, Deborah; Mukherjee, Arnab; Zhang, Haiying; Healey, Paul; Panes, Julian;OCTAVE Induction 1 OCTAVE Inductio.Reference: New England Journal Of Medicine 2017. -
Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease
Authors: Jauregui-Amezaga A, Rovira M, Marín P, Salas A, Pinó-Donnay S, Feu F, Elizalde JI, Fernández-Avilés F, Martínez C, Gutiérrez G, Rosiñol L, Carreras E, Urbano A, Lozano M, Cid J, Suárez-Lledó M, Mensa J, Rimola J, Rodríguez S, Masamunt MC, Comas D, Ruíz I, Ramírez-Morros A, Gallego M, Ordás I, Panés J, Ricart E .Reference: Gut 2016. -
Commensal-Specific CD4(+) Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile
Authors: Calderon-Gomez, Elisabeth; Bassolas-Molina, Helena; Mora-Buch, Rut; Dotti, Isabella; Planell, Nuria; Esteller, Miriam; Gallego, Marta; Marti, Merce; Garcia-Martin, Carme; Martinez-Torro, Carlos; Ordas, Ingrid; Singh, Sharat; Panes, Julian; Benitez-Ribas, Daniel; Salas, Azucena;.Reference: Gastroenterology 2016. -
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: A phase 3 randomised, double-blind controlled trial
Authors: Panes J; Garcia-Olmo D; Van Assche G; Colombel JF; Reinisch W; Baumgart DC; Dignass A; Nachury M; Ferrante M; Kazemi-Shirazi L; Grimaud JC; de la Portilla F; Goldin E; Richard MP; Leselbaum A; Danese S.Reference: Lancet 2016. -
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease
Authors: Rimola, J; Rodriguez, S; Garcia-Bosch, O; Ordas, I; Ayala, E; Aceituno, M; Pellise, M; Ayuso, C; Ricart, E; Donoso, L; Panes, J.Reference: Gut 2009.
Featured Projects
-
Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)
Principal investigator: Maria Azucena Salas Martinez, Julian Panes DiazFunder: Ministerio de Ciencia, Innovación y Universidades (Programa financiador competitivo)Code: RTI2018-096946-B-I00Duration: 01/01/2019 - 31/12/2021 -
Efficacy and safety of autologous hematopoietic stem cells transplantation for refractory Crohn's disease
Principal investigator: Elena RicartFunder: Instituto de Salud Carlos III (Programa financiador competitivo)Code: PI17/00513Duration: 01/01/2018 - 31/12/2020 -
IBD over time: Cellular Mechanisms in Crohn’s Disease Revealing new therapeutic avenues
Principal investigator: Maria Azucena Salas MartinezFunder: The Leona M and Harry B Helmsley Charitable TrustCode: HemsleyDuration: 02/01/2014 - 31/12/2017 -
New siRNA nanotherapy for inflammatory bowel diseases, targeting Janus kinase 3
Principal investigator: Fabrice Navarro, Maria Azucena Salas Martinez, Julian Panes DiazCode: NEW DEAL H2020Duration: 01/01/2017 - 31/12/2020 -
Autologous Hematopoietic Stem Cell Transplant in Crohn's Disease: genetic, Immune and Microbiome factors involved in disease control (TrIM)
Principal investigator: Julian Panes DiazCode: SAF 2012-33560Duration: 02/01/2013 - 31/12/2015